Prof Perry Pickhardt and Diana Samuel talk about the prognostic abilities of a panel of automated CT-based biomarkers for predicting future risk of serious adverse events.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv